Christoph Kahl

6.1k total citations
96 papers, 1.9k citations indexed

About

Christoph Kahl is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Christoph Kahl has authored 96 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Christoph Kahl's work include Colorectal Cancer Treatments and Studies (34 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Lung Cancer Treatments and Mutations (12 papers). Christoph Kahl is often cited by papers focused on Colorectal Cancer Treatments and Studies (34 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Lung Cancer Treatments and Mutations (12 papers). Christoph Kahl collaborates with scholars based in Germany, United States and Austria. Christoph Kahl's co-authors include Sebastian Stintzing, Volker Heinemann, Ludwig Fischer von Weikersthal, Dominik Paul Modest, Frank Kullmann, Werner Scheithauer, Tobias Heintges, Thomas Decker, Alexander Kiani and Andreas Jung and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Christoph Kahl

89 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Kahl Germany 26 1.1k 476 388 287 254 96 1.9k
Constantine A. Axiotis United States 25 535 0.5× 379 0.8× 161 0.4× 733 2.6× 339 1.3× 65 2.3k
Pascale Levine United States 20 518 0.5× 168 0.4× 399 1.0× 325 1.1× 196 0.8× 91 1.7k
A. De Muret France 27 685 0.6× 402 0.8× 544 1.4× 810 2.8× 254 1.0× 120 2.4k
Randa Alsabeh United States 25 554 0.5× 325 0.7× 281 0.7× 173 0.6× 465 1.8× 40 1.8k
Christopher Siegel United States 21 751 0.7× 259 0.5× 209 0.5× 179 0.6× 535 2.1× 51 2.4k
François Lefrère France 26 822 0.8× 211 0.4× 1.1k 2.9× 362 1.3× 187 0.7× 79 2.9k
F Caracciolo Italy 19 506 0.5× 254 0.5× 451 1.2× 255 0.9× 124 0.5× 82 1.5k
M Boiocchi Italy 31 1.8k 1.7× 376 0.8× 1.2k 3.2× 481 1.7× 660 2.6× 94 3.3k
John V. Scholes United States 25 420 0.4× 751 1.6× 197 0.5× 419 1.5× 248 1.0× 51 2.0k
Wilson M. S. Tsui China 24 654 0.6× 528 1.1× 150 0.4× 363 1.3× 241 0.9× 51 1.9k

Countries citing papers authored by Christoph Kahl

Since Specialization
Citations

This map shows the geographic impact of Christoph Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kahl more than expected).

Fields of papers citing papers by Christoph Kahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kahl. The network helps show where Christoph Kahl may publish in the future.

Co-authorship network of co-authors of Christoph Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kahl. A scholar is included among the top collaborators of Christoph Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kahl. Christoph Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jacobs, Bénédikt, Christoph Kahl, Christian Koenecke, et al.. (2024). Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients. European Journal Of Haematology. 112(4). 641–649.
3.
Holch, Julian Walter, Sebastian Stintzing, Kathrin Heinrich, et al.. (2024). Refining first-line treatment decision in RAS wildtype (RAS-WT) metastatic colorectal cancer (mCRC) by combining clinical biomarkers: Results of the randomized phase 3 trial FIRE-3 (AIO KRK0306).. Journal of Clinical Oncology. 42(3_suppl). 13–13. 1 indexed citations
4.
Klein‐Scory, Susanne, Alexander Baraniskin, Wolff Schmiegel, et al.. (2024). Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE ‐4.5 study. Molecular Oncology. 19(2). 344–356. 4 indexed citations
5.
Stintzing, Sebastian, Kathrin Heinrich, David Tougeron, et al.. (2023). FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of Clinical Oncology. 41(25). 4143–4153. 32 indexed citations
6.
7.
Stahler, Arndt, Sebastian Stintzing, Jobst C. von Einem, et al.. (2020). Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. European Journal of Cancer. 137. 250–259. 22 indexed citations
8.
Marshall, Emily E., Daniel Malouli, Scott G. Hansen, et al.. (2019). Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity. Science Translational Medicine. 11(501). 22 indexed citations
9.
Xu, Jing, Fuhua Xu, Maralee S. Lawson, et al.. (2017). Anti-Müllerian hormone is a survival factor and promotes the growth of rhesus macaque preantral follicles during matrix-free culture†. Biology of Reproduction. 98(2). 197–207. 42 indexed citations
10.
Modest, Dominik Paul, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.. (2017). Primary tumor location and efficacy of second-line therapy after initial treatment with FOLFIRI in combination with cetuximab or bevacizumab in patients with metastatic colorectal cancer- FIRE-3 (AIOKRK0306).. Journal of Clinical Oncology. 35(15_suppl). 3525–3525. 5 indexed citations
11.
12.
Bishop, Cecily V., Jon D. Hennebold, Christoph Kahl, & Richard L. Stouffer. (2016). Knockdown of Progesterone Receptor (PGR) in Macaque Granulosa Cells Disrupts Ovulation and Progesterone Production1. Biology of Reproduction. 94(5). 109–109. 37 indexed citations
13.
Maschmeyer, Georg, Lars‐Olof Mügge, Michael Aßmann, et al.. (2015). A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010–2012. Journal of Cancer Research and Clinical Oncology. 141(9). 1639–1644. 5 indexed citations
14.
Heinemann, Volker, Dominik Paul Modest, Ludwig Fischer von Weikersthal, et al.. (2014). Gender and tumor location as predictors for efficacy: Influence on endpoints in first-line treatment with FOLFIRI in combination with cetuximab or bevacizumab in the AIO KRK 0306 (FIRE3) trial.. Journal of Clinical Oncology. 32(15_suppl). 3600–3600. 43 indexed citations
15.
Modest, Dominik Paul, Ludwig Fischer von Weikersthal, Sebastian Stintzing, et al.. (2013). FOLFIRI Plus Cetuximab Versus Folfiri Plus Bevacizumab as First-Line Treatment of KRAS-Wildtype Metastatic Colorectal Cancer: German AIO Study Krk-0306 (FIRE-3). Annals of Oncology. 24. iv22–iv22. 13 indexed citations
16.
Kahl, Christoph, Jessica Bonnell, Suja Hiriyanna, et al.. (2010). Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28. Vaccine. 28(35). 5691–5702. 40 indexed citations
17.
Kahl, Christoph, Paula M. Cannon, Jill Oldenburg, A. F. Tarantal, & Donald B. Kohn. (2008). Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors. Gene Therapy. 15(15). 1079–1089. 12 indexed citations
18.
Kahl, Christoph, Alice F. Tarantal, Chang I. Lee, et al.. (2006). Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector. Experimental Hematology. 34(3). 369–381. 21 indexed citations
19.
Kahl, Christoph, Marco Mielcarek, Mineo Iwata, et al.. (2004). Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation. Biology of Blood and Marrow Transplantation. 10(12). 826–833. 9 indexed citations
20.
Kahl, Christoph, Daniel Wolff, Beate Steiner, et al.. (2002). Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Annals of Hematology. 81(11). 646–650. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Constantine A. Axiotis Breakdown of academic impact, for papers by Pascale Levine Breakdown of academic impact, for papers by A. De Muret Breakdown of academic impact, for papers by Randa Alsabeh Breakdown of academic impact, for papers by Christopher Siegel Breakdown of academic impact, for papers by François Lefrère Breakdown of academic impact, for papers by F Caracciolo Breakdown of academic impact, for papers by M Boiocchi Breakdown of academic impact, for papers by John V. Scholes Breakdown of academic impact, for papers by Wilson M. S. Tsui
Rankless by CCL
2026